Abstract
Neurally mediated syncope is being recognized with increasing frequency in young adults and more recently in children. 1–4 Most children undergoing formal orthostatic testing exhibit a vasodepressor or mixed response with a gradual onset of hypotension, often preceded by sinus tachycardia, followed by secondary bradycardia and syncope. 1–3 Few of these patients have a dominant cardioinhibitory response exhibiting sudden onset of bradycardia and syncope without prior hypotension or tachycardia. 1 Syncopal episodes in this group (unusual in the pediatric experience) may present more risk owing to the rapid onset of syncope, prolonged asystole and seizure activity often exhibited. 4 This study reports on the incidence, clinical features, management and outcome of infants and children presenting with dominant Cardioinhibitory syncope.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.